06/20/2017 - 10:18am

The drug had U.S. sales of $15 million for the 12 months ended April 2017, Perrigo said.

06/19/2017 - 2:43pm
The drug is indicated for the control of serum phosphorus in patients with chronic kidney disease.
 
06/16/2017 - 10:46am
The company is distributing the generic in 30-, 90- and 500-count bottle sizes, and has begun shipping the product from its Kentucky distribution center.
 
06/15/2017 - 3:59pm

CVS Health’s April survey found that 88% of respondents are somewhat or very concerned about the high cost of prescription drugs.

06/13/2017 - 3:00pm

The award recognizes character and professional accomplishments, as well as leadership in HDA, the industry and the community.

06/13/2017 - 2:07pm
The drug had U.S. sales of approximately $2.7 billion for the 12 months ended in March, according to QuintilesIMS data.
06/13/2017 - 1:00pm
The Supreme Court has overturned an appeals court decision which said Sandoz had to wait 180 days under federal law after receiving Food and Drug Administration approval to launch its biosimilar of Amgen’s Neupogen (filgrastim), Zarxio (filgrastim-sndz). 
06/12/2017 - 3:20pm

The drug saw U.S. sales of $293 million for the 12 months ended April 2017, according to QuintilesIMS data.

06/12/2017 - 2:36pm

The latest report on generics cost savings, compiled by the QuintilesIMS Institute on behalf of the Association for Accessible Medicines, highlights the key role generics play in healthcare cost savings.